Comparison of Endoscopic Lumbar Decompression and Minimally Invasive Transforaminal Lumbar Interbody Fusion(MIS-TLIF) for Degenerative Lumbar Spondylolisthesis
Launched by QUEEN SAVANG VADHANA MEMORIAL HOSPITAL, THAILAND · Dec 18, 2024
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different surgical treatments for a condition called degenerative lumbar spondylolisthesis, which occurs when one of the bones in the lower back slips out of place. The trial will compare a traditional surgery called Minimally Invasive Transforaminal Lumbar Interbody Fusion (MIS-TLIF) with a newer, less invasive approach called Endoscopic Lumbar Decompression. This research aims to see which method works better for patients who have not found relief from their symptoms through non-surgical treatments for at least three months.
To be eligible for this trial, participants should have a single level of low-grade degenerative spondylolisthesis and no significant instability in their spine. They should also be willing to follow up for at least a year after the surgery. Unfortunately, individuals with severe spinal issues, previous spine surgeries, or certain other medical conditions may not qualify. This trial is not yet recruiting participants, but it promises to offer valuable insights into the best surgical options for those suffering from this condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Single level lumbar degenerative spondylolisthesis (Meyerding Grading Grade I or II).
- • Failed conservative treatment for at least 3 months.
- • No instability evidence of levels of lesion (Consideration from translation more than 5 mm or angulation change more than 10 degree in flexion and extension L-S plain films ).
- • Able to follow up for at least 12 months.
- • Patient who vorantarily agree to participate in research.
- Exclusion Criteria:
- • Patients with severe foraminal stenosis diagnosed by MRI.
- • Patients who have previously undergone lumbar spine surgery (revision surgery).
- • Patients with other abnormalities in the lumbar spine, such as infection, tumors, or fractures.
- • Patients who cannot undergo surgery due to underlying conditions or who cannot maintain the prone position for extended periods.
About Queen Savang Vadhana Memorial Hospital, Thailand
Queen Savang Vadhana Memorial Hospital, located in Thailand, is a prominent healthcare institution dedicated to advancing medical research and improving patient outcomes. As a clinical trial sponsor, the hospital leverages its state-of-the-art facilities and a multidisciplinary team of experienced healthcare professionals to conduct innovative studies across various therapeutic areas. Committed to ethical standards and patient safety, the hospital aims to contribute to the global medical community by fostering collaboration and facilitating the development of new treatments and interventions. Through its clinical trials, Queen Savang Vadhana Memorial Hospital strives to enhance healthcare delivery and promote evidence-based practices in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chon Buri, , Thailand
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported